Bloomberg Law’s® extensive network of reporters and editors provides comprehensive authoritative coverage of significant developments and issues in product safety and liability...
Boston Scientific Corp. lost its appeal following a consolidated pelvic mesh trial that resulted in a verdict of more than $8 million to two West Virginia women.
A trial court didn’t err by consolidating four cases together for trial, the U.S. Court of Appeals for the Fourth Circuit held Feb. 6.
The jury returned verdicts for all four plaintiffs, awarding over $4 million to each. The awards ranged from $4.25 million to $5.25 million. Two plaintiffs later settled.
All four women received the Obtryx Transobturator Mid-Urethral Sling System. The product is designed to treat stress urinary incontinence.
The women alleged the mesh devices caused pelvic pain and other complications.
Common legal and factual questions formed a substantial part of each suit, the appeals court said.
“There is little reason to be suspicious of the verdicts given that BSC had a chance to fully develop its defenses and that the judge properly instructed the jury throughout the trial to keep the cases separate,” the court said.
The appeals court also rejected Boston Scientific’s evidentiary challenges.Powell & Majestro PLLC, represented the plaintiffs.Shook, Hardy & Bacon represented Boston Scientific.
The case is Campbell v. Boston Scientific Corp. , 4th Cir., No. 16-2279, 2/6/18 .
To contact the reporter on this story: Julie A. Steinberg in Washington at email@example.com
To contact the editor responsible for this story: Steven Patrick at firstname.lastname@example.org
Copyright © 2018 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)